US Stock MarketDetailed Quotes

enGene Therapeutics (ENGN)

Watchlist

1.540
+0.100+6.94%

Close May 13 16:00 ET

1.560
+0.020+1.30%

Pre 08:17 ET

103.16MMarket Cap-0.66P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

enGene Therapeutics (ENGN) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jan 31, 2026

(FY)Oct 31, 2025

(Q4)Oct 31, 2025

(Q3)Jul 31, 2025

(Q2)Apr 30, 2025

(Q1)Jan 31, 2025

(FY)Oct 31, 2024

(Q4)Oct 31, 2024

(Q3)Jul 31, 2024

(Q2)Apr 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-12.48%-28.9M

-105.54%-99.24M

-27.57%-24.96M

-256.97%-25.63M

-62.03%-22.95M

-248.66%-25.7M

-95.13%-48.28M

-188.78%-19.57M

1.63%-7.18M

-218.68%-14.16M

Net income from continuing operations

-20.86%-29.75M

-112.73%-117.3M

-147.60%-37.88M

-104.91%-28.99M

-72.28%-25.82M

-129.82%-24.62M

44.81%-55.14M

81.46%-15.3M

-199.75%-14.15M

-183.68%-14.98M

Operating gains losses

338.58%557K

-99.21%3K

-150.00%-25K

-61.11%7K

-82.76%-106K

-70.60%127K

-97.30%382K

-100.05%-10K

100.33%18K

67.78%-58K

Depreciation and amortization

85.29%189K

57.59%509K

106.02%171K

58.54%130K

35.90%106K

27.50%102K

84.57%323K

69.39%83K

90.70%82K

110.81%78K

Other non cash items

61.89%429K

27.14%1.23M

73.03%462K

-8.37%241K

6.45%264K

38.74%265K

-43.07%969K

113.81%267K

-85.71%263K

-60.88%248K

Change In working capital

2.42%-2.54M

10,152.63%9.74M

267.84%10.13M

-79.28%1.07M

184.30%1.15M

-210.82%-2.6M

118.38%95K

-329.74%-6.03M

356.05%5.14M

-542.53%-1.36M

-Change in receivables

-176.53%-271K

-129.59%-595K

-141.11%-217K

-118.33%-178K

-22.89%-102K

-108.08%-98K

299.70%2.01M

-143.90%-90K

298.16%971K

75.15%-83K

-Change in prepaid assets

-678.04%-2.42M

126.29%1.99M

150.73%1.99M

185.07%1.36M

-125.45%-1.77M

132.97%419K

-907.46%-7.57M

-8,089.80%-3.92M

-161.31%-1.59M

-504.62%-786K

-Change in payables and accrued expense

104.21%116K

41.64%8.07M

509.37%8.13M

-104.18%-243K

698.17%2.94M

-216.30%-2.75M

359.23%5.7M

-183.68%-1.99M

738.94%5.81M

-163.73%-492K

-Change in other current liabilities

123.21%39K

659.18%274K

637.21%231K

419.51%131K

4,100.00%80K

-554.05%-168K

---49K

---43K

---41K

---2K

Cash from discontinued investing activities

Operating cash flow

-12.48%-28.9M

-105.54%-99.24M

-27.57%-24.96M

-256.97%-25.63M

-62.03%-22.95M

-248.66%-25.7M

-95.13%-48.28M

-188.78%-19.57M

1.63%-7.18M

-218.68%-14.16M

Investing cash flow

Cash flow from continuing investing activities

-48.65%-126.3M

80.04%-25.14M

132.33%40.5M

69,050.00%1.38M

10,126.26%17.95M

-16,691.30%-84.96M

-39,507.86%-125.95M

-90,672.46%-125.27M

98.73%-2K

-1,690.00%-179K

Net PPE purchase and sale

48.83%-153K

-60.54%-1.49M

-83.61%-437K

-35,100.00%-704K

74.86%-45K

40.91%-299K

-190.88%-925K

-72.46%-238K

98.73%-2K

-1,690.00%-179K

Net investment purchase and sale

-48.99%-126.14M

81.08%-23.65M

132.74%40.94M

--2.08M

--17.99M

---84.67M

---125.03M

--0

Cash from discontinued investing activities

Investing cash flow

-48.65%-126.3M

80.04%-25.14M

132.33%40.5M

69,050.00%1.38M

10,126.26%17.95M

-16,691.30%-84.96M

-39,507.86%-125.95M

-90,672.46%-125.27M

98.73%-2K

-1,690.00%-179K

Financing cash flow

Cash flow from continuing financing activities

14,165,900.00%141.66M

-99.43%1.52M

-96.69%1.99M

-1,407.84%-667K

-99.90%199K

-99.99%1K

208.44%265.72M

18.33%60.16M

-99.81%51K

2,392.66%193.51M

Net issuance payments of debt

--1.95M

-105.35%-699K

--0

---699K

--0

-60.76%13.06M

--0

Net common stock issuance

--126.25M

--0

357.27%260.15M

5.72%60.15M

--0

----

Proceeds from stock option exercised by employees

2,352,500.00%23.53M

-63.53%2.22M

18,000.00%1.99M

-37.25%32K

-96.70%199K

--1K

13,754.55%6.1M

-59.26%11K

--51K

--6.03M

Net other financing activities

---10.06M

----

-234.75%-13.58M

--0

-4,832.68%-12.53M

Cash from discontinued financing activities

Financing cash flow

14,165,900.00%141.66M

-99.43%1.52M

-96.69%1.99M

-1,407.84%-667K

-99.90%199K

-99.99%1K

208.44%265.72M

18.33%60.16M

-99.81%51K

2,392.66%193.51M

Net cash flow

Beginning cash position

-71.01%50.15M

112.22%173M

-87.34%32.62M

-78.27%57.55M

-27.21%62.35M

112.22%173M

298.95%81.52M

585.42%257.68M

1,413.37%264.81M

503.61%85.65M

Current changes in cash

87.76%-13.54M

-234.29%-122.85M

120.70%17.53M

-249.44%-24.92M

-102.68%-4.8M

-2,783.29%-110.66M

49.76%91.48M

-292.76%-84.67M

-135.49%-7.13M

5,314.45%179.16M

Effect of exchange rate changes

0.00%1K

--0

0.00%1K

--0

End cash Position

-41.27%36.61M

-71.01%50.15M

-87.34%32.62M

-78.27%57.55M

-27.21%62.35M

112.22%173M

585.42%257.68M

1,413.37%264.81M

Free cash flow

-11.78%-29.06M

-104.70%-100.72M

-28.24%-25.4M

-266.67%-26.34M

-60.32%-22.99M

-230.05%-26M

-96.34%-49.21M

-186.46%-19.81M

3.67%-7.18M

-221.98%-14.34M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Jan 31, 2026	(FY)Oct 31, 2025	(Q4)Oct 31, 2025	(Q3)Jul 31, 2025	(Q2)Apr 30, 2025	(Q1)Jan 31, 2025	(FY)Oct 31, 2024	(Q4)Oct 31, 2024	(Q3)Jul 31, 2024	(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-12.48%-28.9M	-105.54%-99.24M	-27.57%-24.96M	-256.97%-25.63M	-62.03%-22.95M	-248.66%-25.7M	-95.13%-48.28M	-188.78%-19.57M	1.63%-7.18M	-218.68%-14.16M
Net income from continuing operations	-20.86%-29.75M	-112.73%-117.3M	-147.60%-37.88M	-104.91%-28.99M	-72.28%-25.82M	-129.82%-24.62M	44.81%-55.14M	81.46%-15.3M	-199.75%-14.15M	-183.68%-14.98M
Operating gains losses	338.58%557K	-99.21%3K	-150.00%-25K	-61.11%7K	-82.76%-106K	-70.60%127K	-97.30%382K	-100.05%-10K	100.33%18K	67.78%-58K
Depreciation and amortization	85.29%189K	57.59%509K	106.02%171K	58.54%130K	35.90%106K	27.50%102K	84.57%323K	69.39%83K	90.70%82K	110.81%78K
Other non cash items	61.89%429K	27.14%1.23M	73.03%462K	-8.37%241K	6.45%264K	38.74%265K	-43.07%969K	113.81%267K	-85.71%263K	-60.88%248K
Change In working capital	2.42%-2.54M	10,152.63%9.74M	267.84%10.13M	-79.28%1.07M	184.30%1.15M	-210.82%-2.6M	118.38%95K	-329.74%-6.03M	356.05%5.14M	-542.53%-1.36M
-Change in receivables	-176.53%-271K	-129.59%-595K	-141.11%-217K	-118.33%-178K	-22.89%-102K	-108.08%-98K	299.70%2.01M	-143.90%-90K	298.16%971K	75.15%-83K
-Change in prepaid assets	-678.04%-2.42M	126.29%1.99M	150.73%1.99M	185.07%1.36M	-125.45%-1.77M	132.97%419K	-907.46%-7.57M	-8,089.80%-3.92M	-161.31%-1.59M	-504.62%-786K
-Change in payables and accrued expense	104.21%116K	41.64%8.07M	509.37%8.13M	-104.18%-243K	698.17%2.94M	-216.30%-2.75M	359.23%5.7M	-183.68%-1.99M	738.94%5.81M	-163.73%-492K
-Change in other current liabilities	123.21%39K	659.18%274K	637.21%231K	419.51%131K	4,100.00%80K	-554.05%-168K	---49K	---43K	---41K	---2K
Cash from discontinued investing activities
Operating cash flow	-12.48%-28.9M	-105.54%-99.24M	-27.57%-24.96M	-256.97%-25.63M	-62.03%-22.95M	-248.66%-25.7M	-95.13%-48.28M	-188.78%-19.57M	1.63%-7.18M	-218.68%-14.16M
Investing cash flow
Cash flow from continuing investing activities	-48.65%-126.3M	80.04%-25.14M	132.33%40.5M	69,050.00%1.38M	10,126.26%17.95M	-16,691.30%-84.96M	-39,507.86%-125.95M	-90,672.46%-125.27M	98.73%-2K	-1,690.00%-179K
Net PPE purchase and sale	48.83%-153K	-60.54%-1.49M	-83.61%-437K	-35,100.00%-704K	74.86%-45K	40.91%-299K	-190.88%-925K	-72.46%-238K	98.73%-2K	-1,690.00%-179K
Net investment purchase and sale	-48.99%-126.14M	81.08%-23.65M	132.74%40.94M	--2.08M	--17.99M	---84.67M	---125.03M	---125.03M	--0	--0
Cash from discontinued investing activities
Investing cash flow	-48.65%-126.3M	80.04%-25.14M	132.33%40.5M	69,050.00%1.38M	10,126.26%17.95M	-16,691.30%-84.96M	-39,507.86%-125.95M	-90,672.46%-125.27M	98.73%-2K	-1,690.00%-179K
Financing cash flow
Cash flow from continuing financing activities	14,165,900.00%141.66M	-99.43%1.52M	-96.69%1.99M	-1,407.84%-667K	-99.90%199K	-99.99%1K	208.44%265.72M	18.33%60.16M	-99.81%51K	2,392.66%193.51M
Net issuance payments of debt	--1.95M	-105.35%-699K	--0	---699K	--0	--0	-60.76%13.06M	--0	--0	--0
Net common stock issuance	--126.25M	--0	--0	--0	--0	--0	357.27%260.15M	5.72%60.15M	--0	----
Proceeds from stock option exercised by employees	2,352,500.00%23.53M	-63.53%2.22M	18,000.00%1.99M	-37.25%32K	-96.70%199K	--1K	13,754.55%6.1M	-59.26%11K	--51K	--6.03M
Net other financing activities	---10.06M	----	----	----	----	----	-234.75%-13.58M	--0	--0	-4,832.68%-12.53M
Cash from discontinued financing activities
Financing cash flow	14,165,900.00%141.66M	-99.43%1.52M	-96.69%1.99M	-1,407.84%-667K	-99.90%199K	-99.99%1K	208.44%265.72M	18.33%60.16M	-99.81%51K	2,392.66%193.51M
Net cash flow
Beginning cash position	-71.01%50.15M	112.22%173M	-87.34%32.62M	-78.27%57.55M	-27.21%62.35M	112.22%173M	298.95%81.52M	585.42%257.68M	1,413.37%264.81M	503.61%85.65M
Current changes in cash	87.76%-13.54M	-234.29%-122.85M	120.70%17.53M	-249.44%-24.92M	-102.68%-4.8M	-2,783.29%-110.66M	49.76%91.48M	-292.76%-84.67M	-135.49%-7.13M	5,314.45%179.16M
Effect of exchange rate changes	0.00%1K	0.00%1K	--0	--0	--0	0.00%1K	0.00%1K	--0	--0	--0
End cash Position	-41.27%36.61M	-71.01%50.15M	-71.01%50.15M	-87.34%32.62M	-78.27%57.55M	-27.21%62.35M	112.22%173M	112.22%173M	585.42%257.68M	1,413.37%264.81M
Free cash flow	-11.78%-29.06M	-104.70%-100.72M	-28.24%-25.4M	-266.67%-26.34M	-60.32%-22.99M	-230.05%-26M	-96.34%-49.21M	-186.46%-19.81M	3.67%-7.18M	-221.98%-14.34M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm